(Q28360112)

22 June 2017

title

Reversal of desferrioxamine induced auditory neurotoxicity during treatment with Ca-DTPA (English)

1 reference

22 June 2017

1 reference

1 reference

1 reference

Wonke B

1

1 reference

22 June 2017

Hoffbrand AV

2

1 reference

22 June 2017

Aldouri M

3

1 reference

22 June 2017

Wickens D

4

1 reference

22 June 2017

Flynn D

5

1 reference

22 June 2017

Stearns M

6

1 reference

22 June 2017

Warner P

7

1 reference

22 June 2017

language of work or name

English

0 references

publication date

1 January 1989

1 reference

Archives of Disease in Childhood

22 June 2017

published in

1 reference

22 June 2017

volume

64

1 reference

22 June 2017

issue

1

1 reference

22 June 2017

page(s)

77-82

1 reference

Tinnitus in a patient with beta-thalassaemia intermedia on long-term treatment with desferrioxamine

22 June 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1791794

Immunochemical quantitation of antigens by single radial immunodiffusion

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1791794

An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1791794

Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1791794

Serum copper and related variables in rheumatoid arthritis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1791794

Chelation therapy for the treatment of thalassemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1791794

Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1791794

Ocular toxicity of high-dose intravenous desferrioxamine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1791794

Iron chelation using subcutaneous infusions of diethylene triamine penta-acetic acid (DTPA).

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1791794

Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1791794

Ocular toxicity of desferrioxamine

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1791794

Combined long-term treatment of hemosiderosis with desferioxamine and DTPA in homozygous beta-thalassemia

2 June 2018

1 reference

12 December 2020

Continuous subcutaenous administration of deferoxamine in patients with iron overload

1 reference

12 December 2020

Rapid desensitisation for desferrioxamine anaphylactic reaction

1 reference

12 December 2020

The measurement of serum magnesium by atomic absorption spectrophotometry

1 reference

12 December 2020

Identifiers

DOI

10.1136/ADC.64.1.77

1 reference

22 June 2017

0 references

1 reference